Mount Sinai Comprehensive Cancer Center received a $1.7 million Department of Defense grant to support the Convergent Science Virtual Cancer Center, aiming to innovate oncology research and education. Additionally, Mount Sinai launched the Samuel Fineman Cardiac Catheterization Artificial Intelligence Laboratory, integrating AI advancements to enhance interventional cardiology and patient care. These initiatives represent the institution’s strategic investment in leveraging cutting-edge technologies to improve cancer therapy development and cardiovascular diagnostics.